Astegolimab
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Clinical data | |
| Other names | AMG282; AMG-282 |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| UNII | |
Astegolimab is a selective
IgG2 monoclonal antibody developed to treat asthma and chronic obstructive pulmonary disease. It is developed by Genentech.[1][2][3][4][5][6]
References
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |